Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2004The Journal of Clinical Endocrinology & MetabolismOpen Access

Inhibition of Nuclear Factor-κB Cascade Potentiates the Effect of a Combination Treatment of Anaplastic Thyroid Cancer Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

DSDmitriy StarenkiHNHiroyuki NambaVSVladimir Saenko

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Starenki et al. (2004) studied this question.

synapsesocial.com/papers/6a706b86f44fa9f079de1014https://doi.org/10.1210/jc.2003-031216
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Clinical Implication of Hot Spot<i>BRAF</i>Mutation, V599E, in Papillary Thyroid Cancers2003 · 539 citations
  2. 2H-Ras Protooncogene Mutations in Human Thyroid Neoplasms*1990 · 110 citations
  3. 3Inhibition of NF-κB Activation by Arsenite through Reaction with a Critical Cysteine in the Activation Loop of IκB Kinase2000 · 359 citations
  4. 4High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.1993 · 654 citations